1 / 18

Neuromuscular Blocking Agents

Neuromuscular Blocking Agents. Pawitra Pulbutr M.Sc. In Pharm (Pharmacology). วัตถุประสงค์เชิงพฤติกรรม.

Télécharger la présentation

Neuromuscular Blocking Agents

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Neuromuscular Blocking Agents Pawitra Pulbutr M.Sc. In Pharm (Pharmacology)

  2. วัตถุประสงค์เชิงพฤติกรรมวัตถุประสงค์เชิงพฤติกรรม • นิสิตมีความรู้ความเข้าใจถึงเภสัชวิทยา กลไกการออกฤทธิ์ เภสัชจลนศาสตร์ การใช้ประโยชน์ทางคลินิก อาการไม่พึงประสงค์ และปฏิกิริยาระหว่างยา ของยาหย่อนกล้ามเนื้อชนิด Non-depolarizing blocking agents และ Depolarizing blocking agents • นิสิตมีความเข้าใจถึงความแตกต่างของการตอบสนองของกล้ามเนื้อต่อ ยาหย่อนกล้ามเนื้อชนิด Non-depolarizing blocking agents และ Depolarizing blocking agents

  3. Muscle relaxing drugs • Neuromuscular blocking agents • Neuromuscular blocker • Acting on NMJ • Use in surgery • Focus here ! • Centrally acting muscle relaxants • Spasmolytic agent • Diazepam, Baclofen • CNS drug • Dantrolene • Direct acting at skeletal muscle

  4. Neuromuscular junction (NMJ) • Junction b/w motor nerve terminal (somatic nerve) and skeletal muscle • NTs = Acetylcholine (ACh) • Motor end plate contain Nicotinic Receptor & AChE Motor nerve NMJ

  5. How to block end plate function ? • Antagonist drugs • Interfere ACh binding to nicotinic RC at end plate • “Non-depolarizing blocking agents” • Prototype = Tubocurarine • Depolarizing block • Excess depolarizing agonist • “Depolarizing blocking agents” • Succinylcholine

  6. Mechanism of action • Non-depolarizing blocking agents • All are this type (except succinylcholine) • Prototype = “Tubocurarine” • Competitive binding with ACh to Nicotinic ACh RC at motor end plate • “Competitive antagonist” • May block in ion channel of RC (Pore blocking) • Also block at prejunctional receptor … Interfere ACh mobilization in nerve

  7. Characteristic of Non-depolarizing blockers • No muscle fasciculation • Tetanic fading • Post tetanic potentiation • Competitive binding with ACh • Antagonism with “AChE inhibitor”… increased ACh

  8. Depolarizing blocking agents • Decamethonium & Suxamethonium (succinylcholine) • Succinylcholine… Only one left • Fast onset & short duration • Phase I block • depolarizing block • Phase II block • desensitization • non-depolarizing block

  9. Phase I block • Depolarizing block • Bind to Nicotinic RC … depolarization • Prolong ion conductance & depolarization • No repolarization • No excitation-contraction coupling • No muscle contraction • Flaccid paralysis • Potentiation by AChE inhibitor

  10. Characteristic of Phase I Block • Muscle fasciculation before relaxation • No tetanic fading … Just lower response • No post tetanic potentiation • Potentiation by AChE inhibitors • Antagonism by Non-depolarizing blocker

  11. Phase II block • Desensitization block • Prolonged succinylcholine • Desensitization of nicotinic RC • Channel block • No response • Non-depolarizing blocking like effect • Antagonism by AChE inhibitor

  12. A = Non-depolarizing blockade … Fading • B = Depolarizing blockade … No fading

  13. A = Post tetanic potentiation … Non-depolarizing blockade • B = No post tetanic potentiation … Depolarizing blockade

  14. Clinical Pharmacology of Neuromuscular blockers • Muscle relaxation in surgery & endotracheal tube insertion • In the past … use deep anesthesia … Danger !... CNS depression • Neuromuscular blocker • No CNS depressant effect

  15. Effects seen only with depolarizing blockade (succinylcholine) • Hyperkalemia • Increased ocular pressure • Increased intragastric pressure • Muscle pain • Malignant hyperthermia

  16. Drug Interaction • Depolarizing agent VS Non-depolarizing agent • Antagonism • Non-depolarizing agent can prevent fasciculation from depolarizing agent • Increase dose of succinylcholine ~ 50-90%

  17. Factors considered before NMB selection • Duration of action • CVS effects • Elimination pathways • ADRs

  18. Make yourself GOOD LUCK for Mid-Term Exam

More Related